Literature DB >> 15758079

Orally administered OVA/CpG-ODN induces specific mucosal and systemic immune response in young and aged mice.

Diego Alignani1, Belkys Maletto, Miriam Liscovsky, Andrea Rópolo, Gabriel Morón, María C Pistoresi-Palencia.   

Abstract

We have previously demonstrated that subcutaneously administered ovalbumin (OVA) plus synthetic oligodeoxynucleotides containing immunostimulatory CpG motifs (CpG-ODN) as adjuvant stimulate cellular and humoral immunity and promote T helper cell type 1 differentiation in aged mice. The present study assessed the ability of CpG-ODN to induce an OVA-specific immune response after oral immunization in young (3-month-old) and aged (18-month-old) BALB/c mice. Oral OVA/CpG-ODN immunization induces a similar OVA-specific T cell-proliferative response (in mucosal and systemic tissues), immunoglobulin G (IgG) in plasma, and IgA in intestinal washes in both groups of ages. The OVA-specific humoral immune response observed in aged mice was similar to the one observed in young mice, peaking at day 7 after the last oral immunization and was present over 40 days after the last oral immunization. The pattern of cytokines released in culture supernatants in both groups of mice was similar, with specific interferon-gamma secretion in the absence of interleukin-5 responses. These results provide evidence that orally administered OVA/CpG-ODN induces a young-like, specific, immune response against OVA in aged mice, showing that CpG-ODN might be used as a mucosal adjuvant during aging.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15758079     DOI: 10.1189/jlb.0604330

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  20 in total

1.  NK-cell-mediated killing of target cells triggers robust antigen-specific T-cell-mediated and humoral responses.

Authors:  Philippe Krebs; Michael J Barnes; Kristin Lampe; Karen Whitley; Keith S Bahjat; Bruce Beutler; Edith Janssen; Kasper Hoebe
Journal:  Blood       Date:  2009-04-30       Impact factor: 22.113

Review 2.  Aging and the immune system.

Authors:  Reginald M Gorczynski; Ender Terzioglu
Journal:  Int Urol Nephrol       Date:  2008-08-06       Impact factor: 2.370

3.  CpG-oligodeoxynucleotide is a potent adjuvant with an Entamoeba histolytica Gal-inhibitable lectin vaccine against amoebic liver abscess in gerbils.

Authors:  Catherine P A Ivory; Kathy Keller; Kris Chadee
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

4.  Mucosal adjuvant activity of flagellin in aged mice.

Authors:  John T Bates; Anna N Honko; Aaron H Graff; Nancy D Kock; Steven B Mizel
Journal:  Mech Ageing Dev       Date:  2008-02-17       Impact factor: 5.432

5.  Interferon-gamma priming is involved in the activation of arginase by oligodeoxinucleotides containing CpG motifs in murine macrophages.

Authors:  Miriam V Liscovsky; Romina P Ranocchia; Carolina V Gorlino; Diego O Alignani; Gabriel Morón; Belkys A Maletto; María C Pistoresi-Palencia
Journal:  Immunology       Date:  2008-09-17       Impact factor: 7.397

6.  Aging impairs murine B cell differentiation and function in primary and secondary lymphoid tissues.

Authors:  Daniela Frasca; Bonnie B Blomberg
Journal:  Aging Dis       Date:  2011-10-28       Impact factor: 6.745

7.  Oral Immunization with Nontoxigenic Clostridium difficile Strains Expressing Chimeric Fragments of TcdA and TcdB Elicits Protective Immunity against C. difficile Infection in Both Mice and Hamsters.

Authors:  Yuanguo Wang; Shaohui Wang; Laurent Bouillaut; Chunhui Li; Zhibian Duan; Keshan Zhang; Xianghong Ju; Saul Tzipori; Abraham L Sonenshein; Xingmin Sun
Journal:  Infect Immun       Date:  2018-10-25       Impact factor: 3.441

Review 8.  Mucosal Immunosenescence in the Gastrointestinal Tract: A Mini-Review.

Authors:  Shintaro Sato; Hiroshi Kiyono; Kohtaro Fujihashi
Journal:  Gerontology       Date:  2014-12-20       Impact factor: 5.140

9.  From allergen to oral vaccine carrier: A new face of ragweed pollen.

Authors:  Md Jasim Uddin; Harvinder Singh Gill
Journal:  Int J Pharm       Date:  2018-05-03       Impact factor: 5.875

10.  Evaluation of recombinant Onchocerca volvulus activation associated protein-1 (ASP-1) as a potent Th1-biased adjuvant with a panel of protein or peptide-based antigens and commercial inactivated vaccines.

Authors:  Wenjun Xiao; Lanying Du; Chao Liang; Jie Guan; Shibo Jiang; Sara Lustigman; Yuxian He; Yusen Zhou
Journal:  Vaccine       Date:  2008-08-19       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.